SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-052029
Filing Date
2015-06-10
Accepted
2015-06-10 18:47:31
Documents
2
Period of Report
2015-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2174
2 POA DOCUMENT poa.txt EX-24.3_589143 3747
  Complete submission text file 0001209191-15-052029.txt   7726
Mailing Address C/O ONCORE BIOPHARMA, INC. 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 215-489-4928
Roivant Sciences Ltd. (Reporting) CIK: 0001635088 (see all company filings)

State of Incorp.: D0 | Fiscal Year End: 0315
Type: 3 | Act: 34 | File No.: 001-37418 | Film No.: 15924473

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-532-8833
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations